{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:36:59Z","timestamp":1790181419141,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":153,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Romanian Ministry of Research, Innovation and Digitization","award":["PN 23.16.01.01"],"award-info":[{"award-number":["PN 23.16.01.01"]}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF22OC0076595"],"award-info":[{"award-number":["NNF22OC0076595"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2016-01267"],"award-info":[{"award-number":["2016-01267"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,31]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>For a comprehensive understanding of the effect of a given treatment on an outcome of interest, quantification of individual treatment heterogeneity is essential, alongside estimation of the average causal effect. However, even in randomized controlled trials, quantities such as the probability of benefit or the probability of harm are not identifiable, since multiple potential outcomes cannot be observed simultaneously for the same individual. We propose a sensitivity analysis for the probability of benefit in randomized controlled trial settings with a binary treatment and a binary outcome, by quantifying the deviation from conditional independence of the two potential outcomes, given a set of measured prognostic baseline covariates. We do this using a marginal sensitivity analysis parameter that does not depend on the number or complexity of the measured covariates. We provide a guide to estimation and interpretation, and illustrate our method in simulations, as well as using a real data example from a randomized controlled trial studying the effect of umbilical vein oxytocin administration on the need for manual removal of the placenta during birth.<\/jats:p>","DOI":"10.1093\/biostatistics\/kxaf011","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:07:54Z","timestamp":1743390474000},"source":"Crossref","is-referenced-by-count":1,"title":["Sensitivity analysis for the probability of benefit in randomized controlled trials with a binary treatment and a binary outcome"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2489-9025","authenticated-orcid":false,"given":"Iuliana","family":"Cioc\u0103nea-Teodorescu","sequence":"first","affiliation":[{"name":"Victor Babe\u015f National Institute of Pathology , Splaiul Independen\u0163ei 99-101 , Bucharest 050096,","place":["Romania"]},{"name":"Carol Davila University of Medicine and Pharmacy , Bulevardul Eroii Sanitari 8 , Bucharest 050474,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0504-8404","authenticated-orcid":false,"given":"Erin E","family":"Gabriel","sequence":"additional","affiliation":[{"name":"Section of Biostatistics, Department of Public Health, University of Copenhagen , \u00d8ster Farimagsgade 5 , Copenhagen DK-1353,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5226-6685","authenticated-orcid":false,"given":"Arvid","family":"Sj\u00f6lander","sequence":"additional","affiliation":[{"name":"Department of Medical Epidmiology and Biostatistics, Karolinska Institute , Stockholm 171 77,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"2026031108022688600_kxaf011-B1","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1002\/sim.2766","article-title":"Non-parametric bounds on treatment effects with non-compliance by covariate adjustment","volume":"26","author":"Cai","year":"2007","journal-title":"Stat Med"},{"key":"2026031108022688600_kxaf011-B2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/biomet\/asac018","article-title":"Sensitivity analysis for unmeasured confounding in the estimation of marginal causal effects","volume":"109","author":"Cioc\u0103nea-Teodorescu","year":"2022","journal-title":"Biometrika"},{"key":"2026031108022688600_kxaf011-B3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1017\/S0266466609990168","article-title":"Sharp bounds on the distribution of treatment effects and their statistical inference","volume":"26","author":"Fan","year":"2010","journal-title":"Econom Theory"},{"key":"2026031108022688600_kxaf011-B4","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/sim.7799","article-title":"Causal estimands and confidence intervals associated with Wilcoxon\u2013Mann\u2013Whitney tests in randomized experiments","volume":"37","author":"Fay","year":"2018","journal-title":"Stat Med"},{"key":"2026031108022688600_kxaf011-B5","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/biomet\/asae020","article-title":"Sharp symbolic nonparametric bounds for measures of benefit in observational and imperfect randomized studies with ordinal outcomes","volume":"111","author":"Gabriel","year":"2024","journal-title":"Biometrika"},{"key":"2026031108022688600_kxaf011-B6","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.0006-341X.2000.00882.x","article-title":"Unit\u2013treatment interaction and its practical consequences","volume":"56","author":"Gadbury","year":"2000","journal-title":"Biometrics"},{"key":"2026031108022688600_kxaf011-B7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-3758(03)00115-0","article-title":"Individual treatment effects in randomized trials with binary outcomes","volume":"121","author":"Gadbury","year":"2004","journal-title":"J Stat Plann Inference"},{"key":"2026031108022688600_kxaf011-B8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1081\/BIP-120008851","article-title":"Evaluating subject-treatment interaction when comparing two treatments","volume":"11","author":"Gadbury","year":"2001","journal-title":"J Biopharm Stat"},{"key":"2026031108022688600_kxaf011-B9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/00031305.2019.1575771","article-title":"On causal inferences for personalized medicine: how hidden causal assumptions led to erroneous causal claims about the d-value","volume":"74","author":"Greenland","year":"2020","journal-title":"Am Stat"},{"key":"2026031108022688600_kxaf011-B10","first-page":"308","article-title":"Inequality in treatment benefits: can we determine if a new treatment benefits the many or the few?","volume":"18","author":"Huang","year":"2017","journal-title":"Biostatistics"},{"key":"2026031108022688600_kxaf011-B11","doi-asserted-by":"crossref","first-page":"20160014","DOI":"10.1515\/em-2016-0014","article-title":"The choice of effect measure for binary outcomes: introducing counterfactual outcome state transition parameters","volume":"7","author":"Huitfeldt","year":"2018","journal-title":"Epidemiol Methods"},{"key":"2026031108022688600_kxaf011-B12","doi-asserted-by":"crossref","first-page":"20230012","DOI":"10.1515\/jci-2023-0012","article-title":"Bounding the probabilities of benefit and harm through sensitivity parameters and proxies","volume":"11","author":"Pe\u00f1a","year":"2023","journal-title":"J Causal Inference"},{"key":"2026031108022688600_kxaf011-B13","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-7693-5","volume-title":"Lectures on categorical data analysis","author":"Rudas","year":"2018"},{"key":"2026031108022688600_kxaf011-B14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1198\/000313002753631330","article-title":"The calculus of M-estimation","volume":"56","author":"Stefanski","year":"2002","journal-title":"Am Stat"},{"key":"2026031108022688600_kxaf011-B15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/biomet\/asad030","article-title":"Treatment effect quantiles in stratified randomized experiments and matched observational studies","volume":"111","author":"Su","year":"2024","journal-title":"Biometrika"},{"key":"2026031108022688600_kxaf011-B16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1018912507879","article-title":"Probabilities of causation: bounds and identification","volume":"28","author":"Tian","year":"2000","journal-title":"Ann Math Artif Intell"},{"key":"2026031108022688600_kxaf011-B17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-154-10-201105170-00008","article-title":"Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions","volume":"154","author":"VanderWeele","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026031108022688600_kxaf011-B18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(09)61752-9","article-title":"Umbilical vein oxytocin for the treatment of retained placenta (release study): a double-blind, randomised controlled trial","volume":"375","author":"Weeks","year":"2010","journal-title":"Lancet"},{"key":"2026031108022688600_kxaf011-B19","article-title":"Data from: umbilical vein oxytocin for the treatment of retained placenta (release study): a double-blind, randomised controlled trial","author":"Weeks","year":"2015","journal-title":"Dryad Dataset"},{"key":"2026031108022688600_kxaf011-B20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/rssc.12012","article-title":"Assessing the heterogeneity of treatment effects via potential outcomes of individual patients","volume":"62","author":"Zhang","year":"2013","journal-title":"J R Stat Soc Ser C Appl Stat"}],"container-title":["Biostatistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biostatistics\/article-pdf\/26\/1\/kxaf011\/63418672\/kxaf011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biostatistics\/article-pdf\/26\/1\/kxaf011\/63418672\/kxaf011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:02:34Z","timestamp":1773230554000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biostatistics\/article\/doi\/10.1093\/biostatistics\/kxaf011\/8155299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"URL":"https:\/\/doi.org\/10.1093\/biostatistics\/kxaf011","relation":{},"ISSN":["1468-4357"],"issn-type":[{"value":"1468-4357","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2024,12,31]]},"article-number":"kxaf011"}}